Table 4.
Genotype frequencies of APOE polymorphisms in our population and different Spanish populations of healthy individuals (Control) or individuals with Alzheimer’s disease (AD).
| __ | __ | Genotype Frequencies | __ | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gene | Genotypes | Our Study | Spanish Control | Spanish Control | Spanish Control | Spanish Control | Spanish Control | Spanish AD | Spanish AD | References |
| APOE | ε-2/2 ε-4/4 ε-3/3 ε-2/3 ε-2/4 ε-3/4 | 0.002 0.022 0.668 0.079 0.014 0.212 | 0.005 0.005 0.780 0.100 0.000 0.120 | 0.002 0.008 0.732 0.089 0.009 0.155 | 0.005 0.010 0.672 0.116 0.014 0.164 | 0.002 0.011 0.731 0.070 0.009 0.178 | 0.000 0.010 0.830 0.027 0.005 0.128 | 0.000 0.080 0.580 0.020 0.000 0.320 | 0.001 0.092 0.531 0.051 0.020 0.296 | [51, 52, 54, 56, 58, 61] [63-67] |
| __ | __ | __ | χ2 = 23.37 P<0.001 | χ2 = 34.43 P<0.001 | χ2 = 16.71 P<0.01 | χ2 = 12.23 P<0.01 | χ2 = 22.44 P<0.001 | χ2 = 27.99 P<0.001 | χ2 = 29.43 P<0.001 | __ |
Spanish groups description: control (healthy) individuals from a broad distribution of Spanish regions (n=1286), and other groups from specific regions, such as Asturias (n=250), Barcelona (n=478), and Navarra (n=188). Table also includes two Spanish groups with individuals diagnosed with Alzheimer Disease from Navarra (n=98) and Asturias (n=120).